Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1946 7
1947 3
1948 7
1949 9
1950 6
1951 7
1952 14
1953 6
1954 7
1955 11
1956 8
1957 7
1958 6
1959 5
1960 5
1961 6
1962 6
1963 9
1964 12
1965 6
1966 6
1967 7
1968 9
1969 13
1970 12
1971 14
1972 16
1973 20
1974 9
1975 18
1976 15
1977 16
1978 24
1979 17
1980 22
1981 16
1982 22
1983 21
1984 24
1985 47
1986 53
1987 56
1988 62
1989 63
1990 85
1991 81
1992 140
1993 158
1994 203
1995 223
1996 228
1997 192
1998 186
1999 176
2000 193
2001 158
2002 152
2003 142
2004 140
2005 146
2006 140
2007 131
2008 127
2009 116
2010 103
2011 119
2012 107
2013 113
2014 95
2015 92
2016 74
2017 62
2018 62
2019 55
2020 68
2021 80
2022 41
2023 57
2024 42
2025 55
2026 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,808 results

Results by year

Filters applied: . Clear all
Page 1
Suramin.
Eisenberger MA, Reyno LM. Eisenberger MA, et al. Cancer Treat Rev. 1994 Jul;20(3):259-73. doi: 10.1016/0305-7372(94)90003-5. Cancer Treat Rev. 1994. PMID: 8020006 Review. No abstract available.
100 Years of Suramin.
Wiedemar N, Hauser DA, Mäser P. Wiedemar N, et al. Antimicrob Agents Chemother. 2020 Feb 21;64(3):e01168-19. doi: 10.1128/AAC.01168-19. Print 2020 Feb 21. Antimicrob Agents Chemother. 2020. PMID: 31844000 Free PMC article. Review.
Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place? Here, we provide an overview of the many different candidate targets of suramin and discuss its modes of action and routes of cellular uptake. We reason that, …
Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place? Here, we provide an overv …
Suramin.
Eisenberger MA, Sinibaldi V, Reyno L. Eisenberger MA, et al. Cancer Pract. 1995 May-Jun;3(3):187-9. Cancer Pract. 1995. PMID: 7599677 Review. No abstract available.
Suramin: potential in acute liver failure.
Doggrell SA. Doggrell SA. Expert Opin Investig Drugs. 2004 Oct;13(10):1361-3. doi: 10.1517/13543784.13.10.1361. Expert Opin Investig Drugs. 2004. PMID: 15461564 Review.
Suramin protected 40% of Jo2-treated mice from death and delayed death in the other mice. ...In contrast, suramin does not inhibit necrotic cell death in a rat model of liver transplantation. Inhibition of apoptosis with suramin or other more selective agents …
Suramin protected 40% of Jo2-treated mice from death and delayed death in the other mice. ...In contrast, suramin does not inh …
Suramin awakes?
Pinedo HM, van Rijswijk RE. Pinedo HM, et al. J Clin Oncol. 1992 Jun;10(6):875-7. doi: 10.1200/JCO.1992.10.6.875. J Clin Oncol. 1992. PMID: 1588368 No abstract available.
100 years since the publication of the suramin formula.
Steverding D, Troeberg L. Steverding D, et al. Parasitol Res. 2023 Dec 7;123(1):11. doi: 10.1007/s00436-023-08027-7. Parasitol Res. 2023. PMID: 38057659 Free PMC article. Review.
Ever since its discovery, suramin has also been tested for bioactivity against numerous other infections and diseases. However, sleeping sickness caused by Trypanosoma brucei rhodesiense is the only human disease for which treatment with suramin is currently approve …
Ever since its discovery, suramin has also been tested for bioactivity against numerous other infections and diseases. However, sleep …
Suramin, a novel antitumor compound.
La Rocca RV, Stein CA, Danesi R, Myers CE. La Rocca RV, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):893-8. doi: 10.1016/0960-0760(90)90439-r. J Steroid Biochem Mol Biol. 1990. PMID: 2285603 Review.
Suramin, a polyanionic compound originally synthesized for use as an antiparasitic agent, has recently entered clinical trials for the treatment of a variety of human cancers refractory to conventional modalities of therapy. This is based on suramin's ability to bin …
Suramin, a polyanionic compound originally synthesized for use as an antiparasitic agent, has recently entered clinical trials for th …
Suramin: clinical uses and structure-activity relationships.
McGeary RP, Bennett AJ, Tran QB, Cosgrove KL, Ross BP. McGeary RP, et al. Mini Rev Med Chem. 2008 Nov;8(13):1384-94. doi: 10.2174/138955708786369573. Mini Rev Med Chem. 2008. PMID: 18991754 Review.
Suramin is a polysulfonated polyaromatic symmetrical urea. It is currently used to treat African river blindness and African sleeping sickness. Suramin has also been extensively trialed recently to treat a number of other diseases, including many cancers. ...
Suramin is a polysulfonated polyaromatic symmetrical urea. It is currently used to treat African river blindness and African sleeping …
Suramin-induced neutropenia.
Dawson NA, Lush RM, Steinberg SM, Tompkins AC, Headlee DJ, Figg WD. Dawson NA, et al. Eur J Cancer. 1996 Aug;32A(9):1534-9. doi: 10.1016/0959-8049(96)00139-6. Eur J Cancer. 1996. PMID: 8911114
The time course of neutropenia was unpredictable and occurred both during and following discontinuation of suramin. Neutropenia rapidly resolved with G-CSF. Neither the measured growth factor levels nor plasma suramin concentrations correlated with neutropenia. We c …
The time course of neutropenia was unpredictable and occurred both during and following discontinuation of suramin. Neutropenia rapid …
4,808 results